VA Office of Research and Development

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, VA Office of Research and Development sits in the top decile of US sponsors by registered trial count (#11 of 15,751 sponsors by registered trial count).

1,668 total trials 291 currently recruiting 1108 completed early-phase tilt top decile by trial count

VA Office of Research and Development: 1,668 sponsored US clinical trials, 291 recruiting.

VA Office of Research and Development sponsors 1,668 registered US clinical trials on ClinicalTrials.gov, 291 of them currently recruiting, and 1,108 completed. 124 of these trials are in Phase 3-4 (later-stage) and 236 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is PTSD, with 28 trials.

Top-decile sponsor footprint

VA Office of Research and Development ranks in the top decile of sponsors by registered trial count (#11 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,668 total, page 33 of 34

COMPLETED NA

Implementing Evidence in the Detection and Treatment of Post Stroke Depression

NCT00296140

COMPLETED

Cognitive Impairment in Kidney Disease

NCT00905619

COMPLETED NA

Partners in Dementia Care: A Telephone Care Consultation Intervention Provided to Veterans in Partnership With Local Alzheimer's Association Chapters

NCT00291161

COMPLETED Phase 2

Exhaled Levels of Nitric Oxide

NCT00753948

COMPLETED NA

LINK: Aftercare Monitoring Project

NCT00265512

COMPLETED NA

Treatment of Veterans With Chronic Low Back Pain

NCT00361270

COMPLETED Phase 3

Monoamine Transporters Genotypes: Risk of PTSD and Related Comorbidities

NCT00403455

COMPLETED NA

Effect of Prolonged Electrical Stimulation on Neural Plasticity in Spinal Cord Injury

NCT00387673

COMPLETED NA

Telephone Case Monitoring (TCM) for Veterans With Post-Traumatic Stress Disorder (PTSD)

NCT00288860

COMPLETED NA

Inflammatory Abnormalities in Muscle After Stroke: Effects of Exercise

NCT00387712

COMPLETED NA

Patient Activation in High-Risk Patients With Heart Failure

NCT00260650

COMPLETED NA

Educational Intervention for Knee Pain

NCT00324857

COMPLETED Phase 1

Benefits of 'Repeat Back' Protocols Within A Computer-Based Informed Consent Program

NCT00288899

COMPLETED NA

Implementing Evidence Based Treatment of Hypertension

NCT00265538

COMPLETED NA

Walking Aids in the Management of Knee Osteoarthritis

NCT00223795

COMPLETED Phase 2

Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis

NCT00359736

COMPLETED NA

SUPER Study (Substance Use and PTSD Treatment Effectiveness Research Study)

NCT00265564

COMPLETED Phase 3

Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma

NCT00132301

COMPLETED NA

Use of "Smart Wheelchairs" to Provide Independent Mobility to Visual and Mobility Impairments

NCT00333762

COMPLETED NA

A Colonic Tube to Improve Bowel Function in Spinal Cord Injury

NCT00345397

COMPLETED NA

The Impact of Vocational Rehabilitation on Mentally III Veterans

NCT00333801

COMPLETED NA

Dual Diagnosis Self-Help Referral

NCT00286728

COMPLETED Phase 2

Effect of Self-Management on Improving Sleep Apnea Outcomes

NCT00310310

COMPLETED NA

Spinal Cord Injury Vocational Integration Program (SCI-VIP)

NCT00117806

COMPLETED NA

Vestibular Stimulation to Treat Hemispatial Neglect

NCT00271388

COMPLETED Phase 4

Quetiapine Augmentation for Treatment-resistant PTSD

NCT00292370

COMPLETED NA

Improving Chronic Pain Treatment in Primary Care

NCT00129480

TERMINATED NA

Bone Physiology & Mechanics in Osteomyoplasty Amputation Rehabilitation

NCT00271362

TERMINATED Phase 2

Baclofen Effects on Smoking Urge and Withdrawal

NCT00257894

COMPLETED NA

Orthostatic Hypotension in Rehabilitation Patients

NCT00117585

COMPLETED NA

Health Focused Motivational Treatment for Alcohol Dependent Veterans

NCT00252590

COMPLETED NA

Evaluating the Carter Institute Caregiver Education Program at the VA

NCT00271375

COMPLETED NA

Healthy Lifestyles for Mentally Ill People Who Have Experienced Weight Gain From Their Antipsychotic Medications

NCT00344500

COMPLETED Phase 4

Pharmacological Treatment of Generalized Anxiety Disorder in the Elderly

NCT00701675

COMPLETED

Genetic Predictors of Lithium Response in Bipolar Disorder

NCT00252577

COMPLETED NA

A Study of Blood Pressure and Blood Supply to the Brain in Persons With a Spinal Cord Injury.

NCT00248807

COMPLETED NA

The Use of Skills Training to Augment Compensated Work Therapy (CWT)/VI for Veterans With SMI

NCT00272168

TERMINATED NA

Insulin Resistance in Non-alcoholic Fatty Liver Disease

NCT01289639

COMPLETED NA

Telemedicine Treatment for Veterans With Gulf War Illness

NCT00129454

COMPLETED

Insulin Treatment Variation in Southwestern Diabetics

NCT00148304

COMPLETED Phase 3

Role of Soy Supplementation in Prostate Cancer Development

NCT00255125

COMPLETED NA

Internally Versus Externally Guided Body Weight-Supported Treadmill Training (BWSTT) for Locomotor Recovery Post-stroke

NCT00125619

COMPLETED NA

Effects of Robotic Versus Manually-Assisted Locomotor Training for Individuals With Incomplete Spinal Cord Injury

NCT00127439

COMPLETED

Treatment Outcomes for Ankle Arthritis

NCT00391365

COMPLETED NA

Metabolic Effects of Androgenicity in Aging Men and Women

NCT00680797

COMPLETED Phase 3

Motivational Interviewing to Improve Work Outcomes in Schizophrenia

NCT00261716

COMPLETED NA

A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making

NCT00122135

COMPLETED NA

VA Low Vision Intervention Trial

NCT00223756

COMPLETED NA

Improving the Quality of End-of-Life Communication for Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00106080

COMPLETED NA

Telecommunications System in Sleep Apnea

NCT00232544

← Previous Page 33 of 34 Next →

Phase Distribution

PhaseTrial count
Phase 1 89
Phase 2 147
Phase 3 55
Phase 4 69

What is open in the VA Office of Research and Development pipeline

291 recruiting of 1,668 indexed (17% open); 1,108 completed (66%).

Phase mix: 124 late (III/IV) vs 236 early (I/II) (early-phase heavy).

Top condition: PTSD (28 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.